Tilray, Inc. (TLRY)

Market Cap	1.65B
Revenue (ttm)	628.37M
Net Income (ttm)	-476.80M
Shares Out	590.28M
EPS (ttm)	0.42
PE Ratio	6.64
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,493,429
Open	2.79
Previous Close	2.70
Day's Range	2.73 - 2.85
52-Week Range	2.65 - 13.95
Beta	2.62
Analysts	Hold
Price Target	4.80 (+72.0%)
Earnings Date	Oct 7, 2022

About TLRY

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produ...

• Industry: Pharmaceuticals
• IPO Date: Jul 19, 2018
• CEO: Brendan Kennedy
• Employees: 1,800
• Stock Exchange: NASDAQ
• Ticker Symbol: TLRY

Full Company Profile

Financial Performance

In 2022, Tilray's revenue was $628.37 million, an increase of 22.47% compared to the previous year's $513.09 million. Losses were -$476.80 million, 29.8% more than in 2021.

Financial Statements

Analyst Forecast

According to 25 analysts, the average rating for TLRY stock is "Hold." The 12-month stock price forecast is 4.8, which is an increase of 72.04% from the latest price.

Price Target

$4.8

(72.04% upside)

Analyst Consensus: Hold

Stock Forecasts